Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats
- 8 December 2016
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 32 (2) , 471-481
Abstract
Dietary compounds like flavonoids may offer protection against neurodegeneration. Huntington’s disease (HD) is a neurodegenerative disorder characterized by symptoms like chorea and dementia. 3-Nitropropionic acid (3-NP), a Succinate dehydrogenase (SDH) inhibitor produces behavioral, biochemical and histological changes in the striatum, mimics HD in animals and humans. The present study was designed to examine the protective activity of Rutin (RT), a primary flavonoid from citrus fruits, green tea on 3-NP induced experimental model of HD in rats. Rats were pretreated with Rutin, a potent antioxidant (25 and 50 mg/kg b.w.) orally prior to the intraperitoneally (i.p.) administration of 3-NP (10 mg/kg b.w.) for 14 days. Behavioral assessments were carried out on 5th, 10th and 15th day after 3-NP treatment. Body weight, biochemical and histological studies were analyzed on 15th day. Systemic administration of 3-NP significantly reduced the body weight, locomotor activities (Rota rod, Open field test), memory (Morris water maze) and antioxidants such as Glutathione (GSH) levels, activities of Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GPx), Glutathione-S-transferase (GST), Glutathione reductase (GR). 3-NP also produces striatal damage by increased the levels of lipid peroxides, nitrite, Glial Fibrillary Acidic Protein (GFAP) and activity of Acetylcholine esterase (AchE). Thus, Rutin treatment of 25 and 50 mg/kg b.w. has significantly restored all the biochemical, behavioral and histological alterations caused by the 3-NP through its antioxidant activity. The findings of our study indicates that Rutin may have an important role in protecting the striatum from oxidative/nitrosative insults caused by 3-NP. These results suggest that RT might be a drug of choice to treat HD.Keywords
This publication has 63 references indexed in Scilit:
- Expression of Concern: Role of LOX/COX pathways in 3‐nitropropionic acid‐induced Huntington's Disease‐like symptoms in rats: protective effect of licofeloneBritish Journal of Pharmacology, 2011
- Protection of Fibroblasts (NIH-3T3) against Oxidative Damage by Cyanidin-3-rhamnoglucoside Isolated from Fig Fruits (Ficus caricaL.)Journal of Agricultural and Food Chemistry, 2010
- Rutin protects the neural damage induced by transient focal ischemia in ratsBrain Research, 2009
- Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changesFundamental & Clinical Pharmacology, 2007
- Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approachesJournal of the International Neuropsychological Society, 2007
- Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's diseaseNeurochemistry International, 2006
- Orphenadrine prevents 3‐nitropropionic acid‐induced neurotoxicity in vitro and in vivoBritish Journal of Pharmacology, 2001
- Oral administration of rutoside can ameliorate inflammatory bowel disease in ratsLife Sciences, 1998
- Huntington's disease: Changes in striatal proteins reflect astrocytic gliosisBrain Research, 1982
- Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1979